A modified Delphi study identifies key reporting measures for rheumatoid arthritis, indicating practical implications for specialty pharmacy work.
There was a high survey response rate within each round. Consensus was reached for 13 measures deemed important and usable by specialty pharmacy stakeholders, with most considered moderately/very feasible by specialty pharmacists.
No takes yet. Share an insight, caveat, or question.
Zuckerman et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: